Dancann Pharma A/S Stock Price, News & Analysis
DCPXF
OTC
Company Description
DanCann Pharma A/S (DCPXF) is a Danish biopharmaceutical company founded in 2018, focusing on cannabinoid-powered products. Listed on the Spotlight Stock Market in Copenhagen/Stockholm and OTCQB in the USA, the company has recently published its Q2-2023 report, showcasing its growth and development in the industry.
Stock Performance
$—
0.00%
0.00
Last updated:
- %
Performance 1 year
$1.4M
Market Cap
141.6M
Shares outstanding
Latest News
SEC Filings
No SEC filings available for Dancann Pharma A/S.
Financial Highlights
—
Revenue (TTM)
—
Net Income (TTM)
—
Diluted EPS (TTM)
—
Operating Cash Flow
—
Net Profit Margin
—
Oper. Profit Margin
Upcoming Events
Frequently Asked Questions
What is the market cap of Dancann Pharma A/S (DCPXF)?
The market cap of Dancann Pharma A/S (DCPXF) is approximately 1.4M.
When was DanCann Pharma A/S founded?
DanCann Pharma A/S was founded in 2018.
Where is DanCann Pharma A/S listed?
DanCann Pharma A/S is listed on the Spotlight Stock Market in Copenhagen/Stockholm and side listed on OTCQB Venture Market in the USA.
What is the focus of DanCann Pharma A/S?
DanCann Pharma A/S focuses on developing cannabinoid-powered products in the biopharmaceutical industry.
What recent report did DanCann Pharma A/S publish?
DanCann Pharma A/S recently published its Q2-2023 report, showcasing its growth and development in the industry.
Who is the CEO of DanCann Pharma A/S?
Jeppe Krog Rasmussen is the CEO of DanCann Pharma A/S.